Thomas Spires
Impact in
- Immunology top 10%
- Phagocytosis and Immune Regulation
- Immune cells in cancer
-
- Occupational and environmental lung diseases
- Prostate Cancer Treatment and Research
Papers in
-
- Prostate Cancer Treatment and Research 2
- Lung Cancer Treatments and Mutations 2
- Occupational and environmental lung diseases 2
- Genetics 4
- Estrogen and related hormone effects 4
- Co-authors
- Marco M. Gottardis (5 shared papers)Cheryl A. Rizzo (4 shared papers)Ricardo M. Attar (4 shared papers)Liang Schweizer (2 shared papers)J. Suso Platero (2 shared papers)Michael Quigley (3 shared papers)Tai-An Lin (1 shared paper)Qiuyan Wu (1 shared paper)
- Journals
- Annals of Oncology (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Cancer Research (3 papers)The American Journal of Cardiology (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Thomas Spires
15 papers receiving 812 citations
Thomas Spires's Hit Papers
Peers
Comparison fields: 5 of 78
- Immunology 214
- Pulmonary and Respiratory Medicine 245
- Oncology 165
- Cardiology and Cardiovascular Medicine 105
- Endocrinology, Diabetes and Metabolism 71
Countries citing papers authored by Thomas Spires
This map shows the geographic impact of Thomas Spires's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Spires with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Spires more than expected).
Fields of papers citing papers by Thomas Spires
This network shows the impact of papers produced by Thomas Spires. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Spires. The network helps show where Thomas Spires may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Spires, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743 Hit paper breakdown → | 2022 | 166 |
| 2 | 2020 | 159 | |
| 3 | 2008 | 100 | |
| 4 | 2019 | 96 | |
| 5 | 2020 | 63 | |
| 6 | 2019 | 55 | |
| 7 | 2009 | 41 | |
| 8 | 2006 | 38 | |
| 9 | 2019 | 33 | |
| 10 | 2005 | 21 | |
| 11 | 2021 | 15 | |
| 12 | 2016 | 11 | |
| 13 | 2024 | 10 | |
| 14 | 2022 | 7 | |
| 15 | 2022 | 5 |
About Thomas Spires
Thomas Spires is a scholar working on Pulmonary and Respiratory Medicine, Genetics, Oncology, Endocrinology, Diabetes and Metabolism and Immunology, having authored 15 papers that have together received 820 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Phagocytosis and Immune Regulation (3 papers), Prostate Cancer Treatment and Research (2 papers), Hormonal and reproductive studies (2 papers), Lung Cancer Treatments and Mutations (2 papers), Occupational and environmental lung diseases (2 papers) and Pharmacogenetics and Drug Metabolism (1 paper). The work is most often cited by research in Immunology (214 citations), Pulmonary and Respiratory Medicine (245 citations), Oncology (165 citations), Cardiology and Cardiovascular Medicine (105 citations) and Endocrinology, Diabetes and Metabolism (71 citations). Thomas Spires has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Marco M. Gottardis, Cheryl A. Rizzo, Ricardo M. Attar, Liang Schweizer, J. Suso Platero, Michael Quigley, Tai-An Lin, Qiuyan Wu, Mary Ellen Cvijic and Melissa Yarde. Their work appears in journals such as Annals of Oncology, Bioorganic & Medicinal Chemistry Letters, Cancer Research, The American Journal of Cardiology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.